Cornerstones and divergencies in the implementation and use of liver hypertrophy techniques: results from a nationwide survey for the set-up of the prospective registry.

Hypertrophy techniques Liver failure Liver surgery Morbidity Survey

Journal

Updates in surgery

ISSN: 2038-3312

Titre abrégé: Updates Surg

Pays: Italy

ID NLM: 101539818

Informations de publication

Date de publication:
30 Jul 2024

Historique:

received: 28 05 2024

accepted: 08 07 2024

medline: 31 7 2024

pubmed: 31 7 2024

entrez: 30 7 2024

Statut: aheadofprint

Résumé

The aim of this national survey on liver hypertrophy techniques was to track the trends of their use and implementation in Italy and to detect analogies and heterogeneities among centers. In December 2022, Italian centers with liver resection activity were specifically contacted and asked to fill an online questionnaire composed of 6 sections including a total of 51 questions. 46 Italian centers filled the questionnaire. The proportion of major/total number of liver resections was 27% and the use of hypertrophy techniques was required in 6,2% of cases. The most frequent reason of drop out was disease progression in 58.5% of cases. Most frequently used techniques were PVE and ALPPS with an increasing use of hepatic venous deprivation (HVD). Heterogeneous answers were provided regarding the cutoff values to indicate the need for hypertrophy techniques. Criteria to allocate a patient to different hypertrophy techniques are not standardized. The use of hypertrophy techniques is deep-rooted in Italy, documenting the established value of their role in improving resectability rate. While an evolution of techniques is detectable, still significant heterogeneity is perceived in terms of cutoff values, indications and managing protocols.

Sections du résumé

BACKGROUND BACKGROUND

The aim of this national survey on liver hypertrophy techniques was to track the trends of their use and implementation in Italy and to detect analogies and heterogeneities among centers.

METHODS METHODS

In December 2022, Italian centers with liver resection activity were specifically contacted and asked to fill an online questionnaire composed of 6 sections including a total of 51 questions.

RESULTS RESULTS

46 Italian centers filled the questionnaire. The proportion of major/total number of liver resections was 27% and the use of hypertrophy techniques was required in 6,2% of cases. The most frequent reason of drop out was disease progression in 58.5% of cases. Most frequently used techniques were PVE and ALPPS with an increasing use of hepatic venous deprivation (HVD). Heterogeneous answers were provided regarding the cutoff values to indicate the need for hypertrophy techniques. Criteria to allocate a patient to different hypertrophy techniques are not standardized.

CONCLUSIONS CONCLUSIONS

The use of hypertrophy techniques is deep-rooted in Italy, documenting the established value of their role in improving resectability rate. While an evolution of techniques is detectable, still significant heterogeneity is perceived in terms of cutoff values, indications and managing protocols.

Identifiants

DOI: 10.1007/s13304-024-01945-w PMID: 39080095

pubmed: 39080095

doi: 10.1007/s13304-024-01945-w

pii: 10.1007/s13304-024-01945-w

doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

Informations de copyright

Références

Torzilli G, Serenari M, Viganò L, Cimino M, Benini C, Massani M, Ettorre GM, Cescon M, Ferrero A, Cillo U, Aldrighetti L, Jovine E (2019) Outcomes of enhanced one-stage ultrasound-guided hepatectomy for bilobar colorectal liver metastases compared to those of ALPPS: a multicenter case-match analysis. HPB (Oxford) 21(10):1411–1418. https://doi.org/10.1016/j.hpb.2019.04.001 . (Epub 2019 May 9 PMID: 31078424)

doi: 10.1016/j.hpb.2019.04.001 pubmed: 31078424

Ratti F, Cipriani F, Fiorentini G, Burgio V, Ronzoni M, Della Corte A, Cascinu S, De Cobelli F, Aldrighetti L (2021) Evolution of surgical treatment of colorectal liver metastases in the real world: single center experience in 1212 cases. Cancers (Basel) 13(5):1178. https://doi.org/10.3390/cancers13051178.PMID:33803257;PMCID:PMC7967178

doi: 10.3390/cancers13051178.PMID:33803257;PMCID:PMC7967178 pubmed: 33803257

Ignatavicius P, Oberkofler CE, Chapman WC, DeMatteo RP, Clary BM, D’Angelica MI, Tanabe KK, Hong JC, Aloia TA, Pawlik TM, Hernandez-Alejandro R, Shah SA, Vauthey JN, Torzilli G, Lang H, Line PD, Soubrane O, Pinto-Marques H, Robles-Campos R, Boudjema K, Lodge P, Adam R, Toso C, Serrablo A, Aldrighetti L, DeOliveira ML, Dutkowski P, Petrowsky H, Linecker M, Reiner CS, Braun J, Alikhanov R, Barauskas G, Chan ACY, Dong J, Kokudo N, Yamamoto M, Kang KJ, Fong Y, Rela M, De Aretxabala X, De Santibañes E, Mercado MÁ, Andriani OC, Torres OJM, Pinna AD, Clavien PA (2020) Choices of therapeutic strategies for colorectal liver metastases among expert liver surgeons: a throw of the dice? Ann Surg 272(5):715–722. https://doi.org/10.1097/SLA.0000000000004331 . (PMID: 32833764)

doi: 10.1097/SLA.0000000000004331 pubmed: 32833764

Vennarecci G, Grazi GL, Sperduti I, Busi Rizzi E, Felli E, Antonini M, D’Offizi G, Ettorre GM (2016) ALPPS for primary and secondary liver tumors. Int J Surg 30:38–44. https://doi.org/10.1016/j.ijsu.2016.04.031 . (Epub 2016 Apr 22 PMID: 27112834)

doi: 10.1016/j.ijsu.2016.04.031 pubmed: 27112834

Viganò L, Torzilli G, Aldrighetti L, Ferrero A, Troisi R, Figueras J, Cherqui D, Adam R, Kokudo N, Hasegawa K, Guglielmi A, Majno P, Toso C, Krawczyk M, Abu Hilal M, Pinna AD, Cescon M, Giuliante F, de Santibanes E, Costa-Maia J, Pawlik T, Urbani L, Zugna D, CLISCO group (2020) Stratification of major hepatectomies according to their outcome: analysis of 2212 consecutive open resections in patients without cirrhosis. Ann Surg 272(5):827–833. https://doi.org/10.1097/SLA.0000000000004338

doi: 10.1097/SLA.0000000000004338 pubmed: 32925253

Capussotti L, Viganò L, Giuliante F, Ferrero A, Giovannini I, Nuzzo G (2009) Liver dysfunction and sepsis determine operative mortality after liver resection. Br J Surg 96(1):88–94. https://doi.org/10.1002/bjs.6429 . (PMID: 19109799)

doi: 10.1002/bjs.6429 pubmed: 19109799

Mueller M, Breuer E, Mizuno T, Bartsch F, Ratti F, Benzing C, Ammar-Khodja N, Sugiura T, Takayashiki T, Hessheimer A, Kim HS, Ruzzenente A, Ahn KS, Wong T, Bednarsch J, D’Silva M, Koerkamp BG, Jeddou H, López-López V, de Ponthaud C, Yonkus JA, Ismail W, Nooijen LE, Hidalgo-Salinas C, Kontis E, Wagner KC, Gunasekaran G, Higuchi R, Gleisner A, Shwaartz C, Sapisochin G, Schulick RD, Yamamoto M, Noji T, Hirano S, Schwartz M, Oldhafer KJ, Prachalias A, Fusai GK, Erdmann JI, Line PD, Smoot RL, Soubrane O, Robles-Campos R, Boudjema K, Polak WG, Han HS, Neumann UP, Lo CM, Kang KJ, Guglielmi A, Park JS, Fondevila C, Ohtsuka M, Uesaka K, Adam R, Pratschke J, Aldrighetti L, De Oliveira ML, Gores GJ, Lang H, Nagino M, Clavien PA (2021) Perihilar Cholangiocarcinoma - Novel Benchmark Values for Surgical and Oncological Outcomes From 24 Expert Centers. Ann Surg 274(5):780–788. https://doi.org/10.1097/SLA.0000000000005103 . (PMID: 34334638)

doi: 10.1097/SLA.0000000000005103 pubmed: 34334638

Olthof PB, Aldrighetti L, Alikhanov R, Cescon M, Groot Koerkamp B, Jarnagin WR, Nadalin S, Pratschke J, Schmelze M, Sparrelid E, Lang H, Guglielmi A, van Gulik TM, Perihilar Cholangiocarcinoma Collaboration Group (2020) Portal vein embolization is associated with reduced liver failure and mortality in high-risk resections for perihilar cholangiocarcinoma. Ann Surg Oncol 27(7):2311–2318. https://doi.org/10.1245/s10434-020-08258-3

doi: 10.1245/s10434-020-08258-3 pubmed: 32103419 pmcid: 7311501

Guglielmi A, Ruzzenente A, Conci S, Valdegamberi A, Iacono C (2012) How much remnant is enough in liver resection? Dig Surg 29(1):6–17. https://doi.org/10.1159/000335713 . (Epub 2012 Mar 15 PMID: 22441614)

doi: 10.1159/000335713 pubmed: 22441614

Ratti F, Pulitanò C, Catena M, Paganelli M, Aldrighetti L (2016) Serum levels of endothelin-1 after liver resection as an early predictor of postoperative liver failure. A prospective study Hepatol Res 46(6):529–540. https://doi.org/10.1111/hepr.12585 . (Epub 2015 Oct 2 PMID: 26331638)

doi: 10.1111/hepr.12585 pubmed: 26331638

Korenblik R, van Zon JFJA, Olij B, Heil J, Dewulf MJL, Neumann UP, Olde Damink SWM, Binkert CA, Schadde E, van der Leij C, van Dam RM (2022) Resectability of bilobar liver tumours after simultaneous portal and hepatic vein embolization versus portal vein embolization alone: meta-analysis. BJS Open 6(6):141. https://doi.org/10.1093/bjsopen/zrac141

doi: 10.1093/bjsopen/zrac141

Jaeck D, Bachellier P, Nakano H, Oussoultzoglou E, Weber JC, Wolf P, Greget M (2003) One or two-stage hepatectomy combined with portal vein embolization for initially nonresectable colorectal liver metastases. Am J Surg 185(3):221–229. https://doi.org/10.1016/s0002-9610(02)01373-9 . (PMID: 12620560)

doi: 10.1016/s0002-9610(02)01373-9 pubmed: 12620560

Schnitzbauer AA, Lang SA, Goessmann H, Nadalin S, Baumgart J, Farkas SA, Fichtner-Feigl S, Lorf T, Goralcyk A, Hörbelt R, Kroemer A, Loss M, Rümmele P, Scherer MN, Padberg W, Königsrainer A, Lang H, Obed A, Schlitt HJ (2012) Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Ann Surg 255(3):405–414. https://doi.org/10.1097/SLA.0b013e31824856f5 . (PMID: 22330038)

doi: 10.1097/SLA.0b013e31824856f5 pubmed: 22330038

Giuliante F, Ardito F, Ferrero A, Aldrighetti L, Ercolani G, Grande G, Ratti F, Giovannini I, Federico B, Pinna AD, Capussotti L, Nuzzo G (2014) Tumor progression during preoperative chemotherapy predicts failure to complete 2-stage hepatectomy for colorectal liver metastases: results of an Italian multicenter analysis of 130 patients. J Am Coll Surg 219(2):285–294. https://doi.org/10.1016/j.jamcollsurg.2014.01.063 . (Epub 2014 Apr 13 PMID: 24933714)

doi: 10.1016/j.jamcollsurg.2014.01.063 pubmed: 24933714

Lang H, de Santibañes E, Schlitt HJ, Malagó M, van Gulik T, Machado MA, Jovine E, Heinrich S, Ettorre GM, Chan A, Hernandez-Alejandro R, Robles Campos R, Sandström P, Linecker M, Clavien PA (2019) 10th anniversary of ALPPS-lessons learned and quo vadis. Ann Surg 269(1):114–119. https://doi.org/10.1097/SLA.0000000000002797 . (PMID: 29727331)

doi: 10.1097/SLA.0000000000002797 pubmed: 29727331

Settmacher U, Ali-Deeb A, Coubeau L, Cillo U, Line PD, Guba M, Nadalin S, Rauchfuß F (2023) Auxilliary liver transplantation according to the RAPID procedure in noncirrhotic patients: technical aspects and early outcomes. Ann Surg 277(2):305–312. https://doi.org/10.1097/SLA.0000000000005726 . (Epub 2022 Oct 13 PMID: 36226590)

doi: 10.1097/SLA.0000000000005726 pubmed: 36226590

Heil J, Schiesser M, Schadde E (2022) Current trends in regenerative liver surgery: novel clinical strategies and experimental approaches. Front Surg 7(9):903825. https://doi.org/10.3389/fsurg.2022.903825.PMID:36157407;PMCID:PMC9491020

doi: 10.3389/fsurg.2022.903825.PMID:36157407;PMCID:PMC9491020

Ratti F, Soldati C, Catena M, Paganelli M, Ferla G, Aldrighetti L (2010) Role of portal vein embolization in liver surgery: single centre experience in sixty-two patients. Updates Surg 62(3–4):153–159. https://doi.org/10.1007/s13304-010-0033-8 . (Epub 2010 Nov 30 PMID: 21116886)

doi: 10.1007/s13304-010-0033-8 pubmed: 21116886

Guiu B, Chevallier P, Denys A, Delhom E, Pierredon-Foulongne MA, Rouanet P, Fabre JM, Quenet F, Herrero A, Panaro F, Baudin G, Ramos J (2016) Simultaneous trans-hepatic portal and hepatic vein embolization before major hepatectomy: the liver venous deprivation technique. Eur Radiol 26(12):4259–4267. https://doi.org/10.1007/s00330-016-4291-9 . (Epub 2016 Apr 18 PMID: 27090112)

doi: 10.1007/s00330-016-4291-9 pubmed: 27090112

Della Corte A, Fiorentini G, Ratti F, Cipriani F, Canevari C, Catena M, Gusmini S, Augello L, Palumbo D, Guazzarotti G, Aldrighetti L, De Cobelli F (2022) Combining laparoscopic liver partitioning and simultaneous portohepatic venous deprivation for rapid liver hypertrophy. J Vasc Interv Radiol 33(5):525–529. https://doi.org/10.1016/j.jvir.2022.01.018 . (PMID: 35489784)

doi: 10.1016/j.jvir.2022.01.018 pubmed: 35489784

Korenblik R, Olij B, Aldrighetti LA, Hilal MA, Ahle M, Arslan B, van Baardewijk LJ, Baclija I, Bent C, Bertrand CL, Björnsson B, de Boer MT, de Boer SW, Bokkers RPH, Rinkes IHMB, Breitenstein S, Bruijnen RCG, Bruners P, Büchler MW, Camacho JC, Cappelli A, Carling U, Chan BKY, Chang DH, Choi J, Font JC, Crawford M, Croagh D, Cugat E, Davis R, De Boo DW, De Cobelli F, De Wispelaere JF, van Delden OM, Delle M, Detry O, Díaz-Nieto R, Dili A, Erdmann JI, Fisher O, Fondevila C, Fretland Å, Borobia FG, Gelabert A, Gérard L, Giuliante F, Gobardhan PD, Gómez F, Grünberger T, Grünhagen DJ, Guitart J, Hagendoorn J, Heil J, Heise D, Herrero E, Hess GF, Hoffmann MH, Iezzi R, Imani F, Nguyen J, Jovine E, Kalff JC, Kazemier G, Kingham TP, Kleeff J, Kollmar O, Leclercq WKG, Ben SL, Lucidi V, MacDonald A, Madoff DC, Manekeller S, Martel G, Mehrabi A, Mehrzad H, Meijerink MR, Menon K, Metrakos P, Meyer C, Moelker A, Modi S, Montanari N, Navines J, Neumann UP, Peddu P, Primrose JN, Qu X, Raptis D, Ratti F, Ridouani F, Rogan C, Ronellenfitsch U, Ryan S, Sallemi C, Moragues JS, Sandström P, Sarriá L, Schnitzbauer A, Serenari M, Serrablo A, Smits MLJ, Sparrelid E, Spüntrup E, Stavrou GA, Sutcliffe RP, Tancredi I, Tasse JC, Udupa V, Valenti D, Fundora Y, Vogl TJ, Wang X, White SA, Wohlgemuth WA, Yu D, Zijlstra IAJ, Binkert CA, Bemelmans MHA, van der Leij C, Schadde E, van Dam RM. 2022 Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) Hypertrophy. Cardiovasc Intervent Radiol, 45(9), 1391–1398. https://doi.org/10.1007/s00270-022-03176-1 .

Serenari M, Ratti F, Guglielmo N, Zanello M, Mocchegiani F, Lenzi J, Colledan M, Mazzaferro V, Cillo U, Ferrero A, Cescon M, Di Benedetto F, Massani M, Grazi G, Valle RD, Vivarelli M, Ettorre GM, Aldrighetti L, Jovine E, ALPPS Italian Registry (2023) Evolution of minimally invasive techniques and surgical outcomes of ALPPS in Italy: a comprehensive trend analysis over 10 years from a national prospective registry. Surg Endosc. https://doi.org/10.1007/s00464-023-09937-4

doi: 10.1007/s00464-023-09937-4 pubmed: 37166554

Serenari M, Zanello M, Schadde E, Toschi E, Ratti F, Gringeri E, Masetti M, Cillo U, Aldrighetti L, Jovine E (2016) Importance of primary indication and liver function between stages: results of a multicenter Italian audit of ALPPS 2012–2014. HPB (Oxford) 18(5):419–427. https://doi.org/10.1016/j.hpb.2016.02.003

doi: 10.1016/j.hpb.2016.02.003 pubmed: 27154805

Eysenbach G (2004) Improving the quality of web surveys: the checklist for reporting results of internet E-surveys (CHERRIES). J Med Internet Res 6(3):e34. https://doi.org/10.2196/jmir.2042

doi: 10.2196/jmir.2042 pubmed: 15471760 pmcid: 1550605

Mathew G, Agha R, for the STROCSS Group (2021) STROCSS 2021: strengthening the Reporting of cohort, cross-sectional and case-control studies in Surgery. Int J Surg 96:106165

doi: 10.1016/j.ijsu.2021.106165 pubmed: 34774726

Panaro F, Giannone F, Riviere B, Sgarbura O, Cusumano C, Deshayes E, Navarro F, Guiu B, Quenet F (2019) Perioperative impact of liver venous deprivation compared with portal venous embolization in patients undergoing right hepatectomy: preliminary results from the pioneer center. Hepatobiliary Surg Nutr 8(4):329–337. https://doi.org/10.21037/hbsn.2019.07.06.PMID:31489302;PMCID:PMC6700017

doi: 10.21037/hbsn.2019.07.06.PMID:31489302;PMCID:PMC6700017 pubmed: 31489302 pmcid: 6700017

Wanis KN, Linecker M, Madenci AL, Müller PC, Nüssler N, Brusadin R, Robles-Campos R, Hahn O, Serenari M, Jovine E, Lehwald N, Knoefel WT, Reese T, Oldhafer K, de Santibañes M, Ardiles V, Lurje G, Capelli R, Enne M, Ratti F, Aldrighetti L, Zhurbin AS, Voskanyan S, Machado M, Kitano Y, Adam R, Chardarov N, Skipenko O, Ferri V, Vicente E, Tomiyama K, Hernandez-Alejandro R (2021) Variation in complications and mortality following ALPPS at early-adopting centers. HPB (Oxford) 23(1):46–55. https://doi.org/10.1016/j.hpb.2020.04.009

doi: 10.1016/j.hpb.2020.04.009 pubmed: 32456975

Huang HC, Bian J, Bai Y, Lu X, Xu YY, Sang XT, Zhao HT (2019) Complete or partial split in associating liver partition and portal vein ligation for staged hepatectomy: a systematic review and meta-analysis. World J Gastroenterol 25(39):6016–6024. https://doi.org/10.3748/wjg.v25.i39.6016.PMID:31660037;PMCID:PMC6815793

doi: 10.3748/wjg.v25.i39.6016.PMID:31660037;PMCID:PMC6815793 pubmed: 31660037 pmcid: 6815793

Serenari M, Ratti F, Zanello M, Guglielmo N, Mocchegiani F, Di Benedetto F, Nardo B, Mazzaferro V, Cillo U, Massani M, Colledan M, Dalla Valle R, Cescon M, Vivarelli M, Colasanti M, Ettorre GM, Aldrighetti L, Jovine E (2020) Minimally invasive stage 1 to protect against the risk of liver failure: results from the hepatocellular carcinoma series of the associating liver partition and portal vein ligation for staged hepatectomy italian registry. J Laparoendosc Adv Surg Tech A 30(10):1082–1089. https://doi.org/10.1089/lap.2020.0563 . (Epub 2020 Sep 9 PMID: 32907480)

doi: 10.1089/lap.2020.0563 pubmed: 32907480

Olthof PB, Arntz P, Truant S, El Amrani M, Dasari BVM, Tomassini F, Troisi RI, Bennink RJ, Grunhagen D, Chapelle T, Op de Beeck B, Zanoni L, Serenari M, Erdmann JI (2023) Hepatobiliary scintigraphy to predict postoperative liver failure after major liver resection; a multicenter cohort study in 547 patients. HPB (Oxford). https://doi.org/10.1016/j.hpb.2022.12.005

doi: 10.1016/j.hpb.2022.12.005 pubmed: 38185541

Serenari M, Bonatti C, Zanoni L, Peta G, Tabacchi E, Cucchetti A, Ravaioli M, Pettinato C, Bagni A, Siniscalchi A, D’Errico A, Golfieri R, Fanti S, Cescon M (2021) The role of hepatobiliary scintigraphy combined with spect/ct in predicting severity of liver failure before major hepatectomy: a single-center pilot study. Updates Surg. 73(1):197–208. https://doi.org/10.1007/s13304-020-00907-2

doi: 10.1007/s13304-020-00907-2 pubmed: 33136280

Serenari M, Collaud C, Alvarez FA, de Santibañes M, Giunta D, Pekolj J, Ardiles V, de Santibañes E (2018) Interstage assessment of remnant liver function in ALPPS using hepatobiliary scintigraphy: prediction of posthepatectomy liver failure and introduction of the HIBA index. Ann Surg 267(6):1141–1147. https://doi.org/10.1097/SLA.0000000000002150 . (PMID: 28121683)

doi: 10.1097/SLA.0000000000002150 pubmed: 28121683

Tomassini F, D’Asseler Y, Giglio MC, Lecluyse C, Lambert B, Sainz-Barriga M, Van Dorpe J, Hoorens A, Geboes K, Troisi RI (2019) Hemodynamic changes in ALPPS influence liver regeneration and function: results from a prospective study. HPB (Oxford) 21(5):557–565. https://doi.org/10.1016/j.hpb.2018.09.005 . (Epub 2018 Oct 10 PMID: 30314713)

doi: 10.1016/j.hpb.2018.09.005 pubmed: 30314713